Add to ORKGWe hypothesized that the increased prevalence of Non-Infectious Co-Morbidities observed among HIV-related patients, when compared to the general population, may result in an increased direct cost of medical care. The objective was to provide estimates and determinants of direct cost of medical care
INTRODUCTION:Although HIV infection and its associated co-morbidities remain the commonest reason fo...
Objective: To estimate health care costs associated with medical events identified as antiretroviral...
Objective: To estimate health care costs associated with medical events identified as antiretroviral...
We hypothesized that the increased prevalence of Non-Infectious Co-Morbidities observed among HIV-re...
We hypothesize that the increased prevalence of non-infectious co-morbidities (NICM) observed among ...
OBJECTIVES: We hypothesized that the increased prevalence of noninfectious comorbidities (NICMs) obs...
Abstract Background While previous studies have examined HIV cost expenditures within the United Sta...
This review of published studies on the costs of HIV treatment and care describes some of the recent...
Introduction Although HIV infection and its associated co-morbidities remain the commonest reason fo...
The objectives of this study were firstly to estimate total lifetime care costs for an individual wi...
People living with human immunodeficiency virus (PLHIV) are at high risk of developing non-HIV relat...
We examined the influence of demographic, social and economic background of people with HIV/AIDS in ...
Introduction Although HIV infection and its associated co-morbidities remain the commonest reason...
Purpose To quantify costs to patients of accessing HIV care prior to ART initiation. Materials and m...
International audienceObjectives: As people living with HIV (PLHIV) age, the burden of non-HIV relat...
INTRODUCTION:Although HIV infection and its associated co-morbidities remain the commonest reason fo...
Objective: To estimate health care costs associated with medical events identified as antiretroviral...
Objective: To estimate health care costs associated with medical events identified as antiretroviral...
We hypothesized that the increased prevalence of Non-Infectious Co-Morbidities observed among HIV-re...
We hypothesize that the increased prevalence of non-infectious co-morbidities (NICM) observed among ...
OBJECTIVES: We hypothesized that the increased prevalence of noninfectious comorbidities (NICMs) obs...
Abstract Background While previous studies have examined HIV cost expenditures within the United Sta...
This review of published studies on the costs of HIV treatment and care describes some of the recent...
Introduction Although HIV infection and its associated co-morbidities remain the commonest reason fo...
The objectives of this study were firstly to estimate total lifetime care costs for an individual wi...
People living with human immunodeficiency virus (PLHIV) are at high risk of developing non-HIV relat...
We examined the influence of demographic, social and economic background of people with HIV/AIDS in ...
Introduction Although HIV infection and its associated co-morbidities remain the commonest reason...
Purpose To quantify costs to patients of accessing HIV care prior to ART initiation. Materials and m...
International audienceObjectives: As people living with HIV (PLHIV) age, the burden of non-HIV relat...
INTRODUCTION:Although HIV infection and its associated co-morbidities remain the commonest reason fo...
Objective: To estimate health care costs associated with medical events identified as antiretroviral...
Objective: To estimate health care costs associated with medical events identified as antiretroviral...